"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell component:ch1","cell line:ch1"
"GSM2094904","Exosomes MNT-1_rep1","GSM2094904","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","MNT-1 exosomes","Homo sapiens","cell line: MNT-1","cell component: exosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from MNT-1 exosomes replicate 1","EXO 1","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094904/suppl/GSM2094904_US22502683_257015611462_S01_miRNA_107_Sep09_1_1.txt.gz","5901","exosomes","MNT-1"
"GSM2094905","Exosomen_MNT-1_rep2","GSM2094905","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","MNT-1 exosomes","Homo sapiens","cell line: MNT-1","cell component: exosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from MNT-1 exosomes replicate 2","EXO 2","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094905/suppl/GSM2094905_US22502683_257015611462_S01_miRNA_107_Sep09_1_2.txt.gz","5901","exosomes","MNT-1"
"GSM2094906","Secreted melanosomes MNT-1_rep1","GSM2094906","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","MNT-1 secreted melanosomes","Homo sapiens","cell line: MNT-1","cell component: secreted melanosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from secreted melanosomes of MNT-1 cells replicate 1","SMEL 1","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094906/suppl/GSM2094906_US22502683_257015611462_S01_miRNA_107_Sep09_1_3.txt.gz","5901","secreted melanosomes","MNT-1"
"GSM2094907","Secreted melanosomes MNT-1_rep2","GSM2094907","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","MNT-1 secreted melanosomes","Homo sapiens","cell line: MNT-1","cell component: secreted melanosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from secreted melanosomes of MNT-1 cells replicate 2","SMEL 2","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094907/suppl/GSM2094907_US22502683_257015611462_S01_miRNA_107_Sep09_1_4.txt.gz","5901","secreted melanosomes","MNT-1"
"GSM2094908","Whole cells WM3682_rep1","GSM2094908","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","WM3682 melanoma cells","Homo sapiens","cell line: WM3682","cell component: whole cells","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","Cellular RNA of WM3682 melanoma cells","WC 3682","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094908/suppl/GSM2094908_US22502683_257015611462_S01_miRNA_107_Sep09_2_1.txt.gz","5901","whole cells","WM3682"
"GSM2094909","Melanosomes WM3682_rep1","GSM2094909","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","WM3682 melanosomes","Homo sapiens","cell line: WM3682","cell component: melanosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from melanosomes of WM3682 cells","MEL 3682","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094909/suppl/GSM2094909_US22502683_257015611462_S01_miRNA_107_Sep09_2_2.txt.gz","5901","melanosomes","WM3682"
"GSM2094910","Whole cells WM3314_rep1","GSM2094910","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","WM3314 melanoma cells","Homo sapiens","cell line: WM3314","cell component: whole cells","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","Cellular RNA of WM3314 melanoma cells","WC 3314","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094910/suppl/GSM2094910_US22502683_257015611462_S01_miRNA_107_Sep09_2_3.txt.gz","5901","whole cells","WM3314"
"GSM2094911","Melanosomes WM3314_rep1","GSM2094911","Public on Aug 09 2016","Mar 20 2016","Aug 09 2016","RNA","1","WM3314 melanosomes","Homo sapiens","cell line: WM3314","cell component: melanosomes","Melanosomes of WM3682 and WM3314 cells were treated with RNase for 10 min at 37 °C, followed by the addition of RNase inhibitor.","MNT-1, WM3682 and WM3314 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine.","total RNA","RNA of WM3682 and WM3314 cells and melanosomes was extracted with Trizol reagent. RNA from MNT-1 exosomes and secreted melanosomes was isolated using the miRNeasy Mini Kit from Qiagen. Quality control was performed with Agilent Bioanalyzer.","Cy3","Samples were labeled according to the Agilent miRNA Complete Labeling and Hyb kit protocol.","9606","Hybridization was performed in a SureHyb chamber at 55°C for 20h.","Microarray scanning was performed using the Agilent Scanner G2505C.","RNA from melanosomes of WM3314 cells","MEL 3314","The data were quantile normalized and fold-changes were calculated using R/Bioconductor scripts.","GPL21576","Carmit,,Levy","carmitlevy@post.tau.ac.il","Sackler School of Medicine","Human Genetics and Biochemistry","Tel Aviv University","Ramat Aviv","Tel Aviv","69978","Israel","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2094nnn/GSM2094911/suppl/GSM2094911_US22502683_257015611462_S01_miRNA_107_Sep09_2_4.txt.gz","5901","melanosomes","WM3314"
